Chacha Nehru Bal Chikitsalaya, New Delhi Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01349829
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Chacha Nehru Bal Chikitsalaya, New Delhi | Chacha Nehru Bal Chikitsalya, Delhi | Medical College and Chacha Nehru Bal Chikitsalay

Active Ingredients

Drugs in Phase 4 Trials (1)

hepatitis a vaccine, inactivated (vaqta) (1 trial)

Drugs in Phase 3 Trials (2)

beractant (survanta) (1 trial)

poractant alfa (curosurf) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3